Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05579106
Other study ID # CoCo 2021-017
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 8, 2022
Est. completion date December 8, 2022

Study information

Verified date March 2023
Source Leiden University Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Pain (nociception), stress and discomfort are difficult to detect in sedated and intubated patients during mechanical ventilation. In order to improve this several nociception level monitors (NOL) were developed that objectively track nociception in sedated or anesthetized patients. Earlier studies showed that for sedated and intubated patients in the operating room, using such monitors is beneficial in reducing stress hormones and post operative pain scores. In this study the investigators aim to observe whether the NOL could be equally beneficial in managing nociception in sedated and intubated ICU patients.


Description:

To date it remains challenging to adequately titrate analgesic medication in sedated and anesthetized patients. Recently, nociception monitoring was introduced to guide analgesic treatment in sedated and anesthetized surgical patients. One such monitor is the Nociception Level (NOL; Medasense Biometrics Ltd., Israel). The NOL combines various measurements such as, skin conductance, heart rate, heart rate variability and photoplethysmograph amplitude, and translates these inputs into a single index ranging from 0 (no nociception) to 100 (maximal nociception). Earlier studies have shown that during surgery, the NOL-guided opioid treatment resulted in improved hemodynamics and reduced postoperative pain. In the COVID-19 pandemic, patients admitted in the Intensive Care Unit (ICU), needed excessive amounts of sedatives, analgesics and muscle relaxants during mechanical ventilation. To determine its value in the ICU, the investigators measured NOL values in COVID and non-COVID ICU patients in an earlier study. The aim of the investigators was to verify the assumption that COVID-19 patients were overdosed on opioids. Since the investigators indeed did observe lower NOL values in COVID-19 patients than in non-COVID patients in an earlier study, the investigators expanded the study to determine whether sedatives were equally overdosed, by also measuring the bispectral index (BIS). With this extra information the investigators also hope to determine whether it is feasible to use the NOL in the ICU.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date December 8, 2022
Est. primary completion date December 8, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - aged 18 years or older - mechanical ventilation for any reason - deemed suitable by the investigators Exclusion Criteria: - aged 17 years or younger - severe peripheral edema - veno-arterial (VA) and veno-venous (VV) exctracorporeal membrane oxygenation (ECMO) - heart rate below 35 - abdominal position - not deemed suitable by the investigators

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Nociception Level Monitor (NOL) by Medasense Biometrics Ltd., Israel
The NOL monitor measures various parameters via a sensor in a finger probe that is attached to the patient. These parameters are: Temperature Galvanic skin response Accelerometer Photoplethysmograph (pulse rate, pulse rate variability, photoplethysmograph amplitude) All this data is combined in an algorithm which produces a number between 0-100. Between 10-25 indicates adequate analgesia, below 10 too much analgesia, above 25 too little analgesia. No actions are taken based on this measurement.
Bispectral index (BIS)
The BIS processes EEG information to provide a direct measurement of the patient's level of consciousness and insight into the effects of anesthesia on the brain.
Other:
Questionnaire perception of the nurse on pain patient
The investigators developed a questionnaire with 7-questions regarding the perception of the responsible nurse on the pain of the patient. When the investigators measured for 8 hours with the BIS and the NOL they will ask the nurse what his or her perception was of the pain of the patient. Eventually the investigators will compare the answers of this questionnaire with the NOL and BIS values that they observed, whether the information corresponds or not.

Locations

Country Name City State
Netherlands Leiden University Medical Centre Leiden Zuid-holland

Sponsors (1)

Lead Sponsor Collaborator
Leiden University Medical Center

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary BIS and NOL values over time The observation of the BIS and NOL values over time 8 hours
Secondary Propofol and opioid dosage Propofol and opioid dosage will be monitored during 8 hours 8 hours
Secondary Feasibility of using the NOL in the ICU Is it possible to use the NOL on ICU patients and does it monitor correctly 8 hours
See also
  Status Clinical Trial Phase
Completed NCT03277872 - NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope N/A
Enrolling by invitation NCT02485795 - Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management N/A
Active, not recruiting NCT05732896 - Comparison of Opioid Consumption During TCI Guided by NOL Index or Standard Care Undergoing Intracranial Tumor Surgery N/A
Terminated NCT00986258 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability Phase 3
Not yet recruiting NCT04542798 - CRF vs WCRF or PRF-DRG in CLBP of FJ Origin and RFA Failure of MBDR: Central Sensitization and Aberrant Nerve Sprouting N/A
Recruiting NCT05106452 - Effect of ANI on Intraoperative Opioid Consumption
Completed NCT03303651 - Monitor-Guided Analgesia During General Anesthesia - Part I N/A
Completed NCT04137991 - Nol-Index Guided Remifentanil Analgesia Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery N/A
Recruiting NCT05998564 - Comparison of the Skin Conductance Algesimeter and the Nociception Level Index in the Paediatric Population. An Observational Study.
Recruiting NCT05567822 - The Impact of Esmolol Administration on Postoperative Recovery N/A
Completed NCT04567160 - NOL Index to Compare the Intraoperative Analgesic Effect of Propofol Versus Sevoflurane Phase 4
Completed NCT04305015 - Postoperative Benefits of Intraoperative Nociception Level (NOL) Titration - Pilot N/A
Completed NCT03761433 - Intraoperative Nociception and Postoperative Pain
Completed NCT05589935 - Radicle Relief 1: A Study of Health and Wellness Products on Pain and Other Health Outcomes N/A
Completed NCT01979718 - The Post-operative Analgesia of the Virtual Reality Using a Mirror Therapy After Total Knee Arthroplasty N/A
Enrolling by invitation NCT04435821 - PET/MRI in the Diagnosis of Pediatric Chronic Pain Phase 1
Completed NCT03140241 - Pain Assessment by Pupil Dilation Reflex (PDR) and Pupillary Pain Index (PPI) in Response to Noxious Stimulation in Anesthetized Adults N/A
Completed NCT05127200 - Cervical Neuromodulation and Nociceptive Processing N/A
Recruiting NCT06313320 - Intraoperative Electroencephalographic Biomarkers of Postoperative Pain
Not yet recruiting NCT05339737 - The Nociception Level (NOL) Index for Pain Assessment in the Adult Intensive Care Unit